CNTO 148

· Centocor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNTO 148, covering 2012-08-07 to 2012-08-07. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis [Phase 2]

See pricing